Identifying adverse drug reactions associated with drug-drug interactions: Data mining of a spontaneous reporting database in Italy

Drug Safety

Volumn 33, Issue 8, 2010, Pages 667-675

  Leone, Roberto ^a   Magro, Lara ^a   Moretti, Ugo ^a   Cutroneo, Paola ^b   Moschini, Martina ^c   Motola, Domenico ^d   Tuccori, Marco ^e   Conforti, Anita ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

Adverse reaction monitoring; Anticoagulants; Antiplatelets; Digoxin; Diuretics; drug interactions; Drug interactions; Postmarketing surveillance

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; AMIODARONE; CLOPIDOGREL; DIGOXIN; DILTIAZEM; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; HYDROCHLOROTHIAZIDE; LEVOFLOXACIN; PREDNISONE; SIMVASTATIN; TICLOPIDINE;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ACUTE KIDNEY FAILURE; ADVERSE DRUG REACTION; ARTICLE; BLEEDING; BRADYCARDIA; DATA BASE; DATA MINING; DRUG DRUG INTERACTION; DRUG EXPOSURE; DRUG FATALITY; DRUG INTERACTION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; ITALY; LIVER DISEASE; MYOPATHY; NAUSEA; PRIORITY JOURNAL; TACHYCARDIA; TENDINITIS; TENDON RUPTURE; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; VOMITING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DATA MINING; DATABASES, FACTUAL; DRUG INTERACTIONS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; TIME FACTORS;

EID: 77954723643     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11534400-000000000-00000     Document Type: Article

References (49)

1. May FE, Stewart RB, Cluff LE. Drug interactions and multiple drug administration. Clin Pharmacol Ther 1977; 22: 322-8
2. Ferslew KE, Hagardon AN, Harlan GC, et al. A fatal drug interaction between clozapine and fluoxetine. J Forensic Sci 1998; 43: 1082-5
3. Buajordet I, Ebbesen J, Erikssen J, et al. Fatal adverse drug events: the paradox of drug treatment. J Intern Med 2001; 250: 327-41
4. Staffa JA, Cheng J, Green L. Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 2002; 346: 539-40
5. Hung IF, Wu AK, Cheng VC, et al. Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. Clin Infect Dis 2005; 41: 291-300
6. Francis L, Bonilla E, Soforo E, et al. Fatal toxic myopathy attributed to propofol, methylprednisolone, and cyclo-sporine after prior exposure to colchicine and simvastatin. Clin Rheumatol 2008; 27: 129-31
7. Kraft WK, Waldman SA. Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses? Drug Saf 2001; 24: 637-43
8. Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov 2005; 4: 825-33
9. Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993; 9: 51-9
10. Egger T, Dormann H, Ahne G, et al. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 2003; 20: 769-76
11. Weingart SN, Toth M, Sands DZ, et al. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 2003; 163: 2625-31
12. Mille F, Schwartz C, Brion F, et al. Analysis of overridden alerts in a drug-drug interaction detection system. Int J Qual Health Care 2008; 20: 400-5
13. van Puijenbroek EP, Egberts ACG, Heerdink ER, et al. Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol 2000; 56: 733-8
14. Thakhar BT, Grundschober SB, Doessegger L. Detecting signals of drug-drug interactions in a spontaneous reports database. Br J Clin Pharmacol 2007; 64: 489-95
15. Ellis RJ, Mayo MS, Bodensteiner DM. Ciprofloxacin-warfarin coagulopathy: a case series. Am J Hematol 2000; 63: 28-31
16. Knudsen JF, Sokol GH, Flowers CM. Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy. J Clin Pharm Ther 2008; 33: 513-9
17. Tavassoli N, Sonmet A, Lapeyre-Mestre M, et al. Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary). Drug Saf 2007; 30: 1063-71
18. Strandell J, Bate A, Lindquist M, et al. Drug-drug interactions: a preventable patient issue? Br J Clin Pharmacol 2008; 65: 144-6
19. The Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring. The WHO adverse reaction terminology (WHO-ART): terminology for coding clinical information in relation to drug therapy[online]. Available from URL: http://www.umc-products. com/graphics/3149.pdf [Accessed, 2009, Jun, 15]
20. DRUGDEX® system [Internet database]. Greenwood Village (CO): Thomson Reuters (Healthcare) Inc., updated periodically
21. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-9
22. Kohler GI, Bode-Boger SM, Busse R, et al. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 2000; 38: 504-13
23. Glintborg B, Andersen SE, Dalhoff K. Drug-drug interactions among recently hospitalized patients: frequent but mostly clinically insignificant. Eur J Clin Pharmacol 2005; 61: 675-81
24. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admissions to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15-9
25. Davies EC, Green CF, Taylor S, et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 2009; 4 (2): E4439. Epub 2009 Feb 11
26. Ibanez A, Alcala M, Garcia J, et al. Drug-drug interactions in patients from an internal medicine service. Farm Hosp 2008; 32: 293-7
27. Tulner LR, Frankfort SV, Gijsen GJ, et al. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008; 25: 343-55
28. Moore N, Noblet C, Kreft-Jais C, et al. French pharmacovigilance database system: examples of utilisation. Therapie 1995; 50: 557-62
29. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20: 817-32
30. Thomas HF, Sweetnan PM, Janchawee B, et al. Polypharmacy among older men in South Wales. Eur J Clin Pharmacol 1999; 55: 411-5
31. Bjerrum L, Søgaard J, Hallas J, et al. Polypharmacy: correlations with sex, age and drug regimen: a prescription database study. Eur J Clin Pharmacol 1998; 54: 197-202
32. Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294-300
33. Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944-8
34. Collins P, Stevenson JC, Mosca L. Spotlight on gender. Cardiovasc Res 2002; 53: 535-7
35. Ng MKC. New perspectives on Mars and Venus: unravelling the role of androgens in gender differences in cardiovascular biology and disease. Heart Lung Circ 2007; 16: 185-92
36. Saini M, Shuaib A. Stroke in women. Recent Pat Cardiovasc Drug Discov 2008; 3: 209-21
37. Magro L, Conforti A, Del Zotti F, et al. Identification of severe potential drug-drug interactions using an Italian general-practitioner database. Eur J Clin Pharmacol 2008; 64: 303-9
38. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005; 165: 1095-106
39. Rivkin A. Admissions to a medical intensive care unit related. Am J Health Syst Pharm 2007; 64: 1840-3
40. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharma-cother 2008; 42: 1017-25
41. Chan TY. Life-threatening retroperitoneal bleeding due to warfarin-drug interactions. Pharmacoepidemiol Drug Saf 2009; 18: 420-2
42. McClaskey EM, Michalets EL. Subdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and ASA: case report and review of the literature. Pharmacotherapy 2007; 27: 152-60
43. Pennell DJ, Nunan TO, O'Doherty MJ, et al. Fatal StevensJohnson syndrome in a patient on captopril and allopur-inol [letter]. Lancet 1984; I: 463
44. Mehlhorn AJ, Brown DA. Safety concerns with fluoroquinolones. Ann Pharmacother 2007; 41: 1859-66
45. Leone R, Venegoni M, Motola D, et al. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions. Drug Saf 2003; 26: 109-20
46. van der Linden PD, Sturkenboom MCJM, Herings RMC, et al. Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ 2002; 324: 1306-7
47. Thakrar BT, Grunduschober SB, Doessegger L. Detecting signals of drug-drug interactions in a spontaneous reports database. Br J Clin Pharmacol 2007; 64: 489-95
48. Aagaard L, Hansen EH. Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC Clin Pharmacol 2009; 9: 4. Epub 2009 Mar 3
49. Bergk V, Gasse C, Rothembacher D, et al. Drug interactions in primary care: impact of a new algorithm on risk determination. Clin Pharmacol Ther 2004; 76: 85-96